Matthew Hawryluk

2.1k total citations
16 papers, 926 citations indexed

About

Matthew Hawryluk is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Matthew Hawryluk has authored 16 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Matthew Hawryluk's work include Cellular transport and secretion (4 papers), Cancer Genomics and Diagnostics (4 papers) and PARP inhibition in cancer therapy (4 papers). Matthew Hawryluk is often cited by papers focused on Cellular transport and secretion (4 papers), Cancer Genomics and Diagnostics (4 papers) and PARP inhibition in cancer therapy (4 papers). Matthew Hawryluk collaborates with scholars based in United States, United Kingdom and Australia. Matthew Hawryluk's co-authors include Linton M. Traub, Sanjay Mishra, Peter A. Keyel, Roman Yelensky, Vincent A. Miller, Jeffrey S. Ross, Doron Lipson, Kai Wang, Philip J. Stephens and Geoff Otto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Matthew Hawryluk

16 papers receiving 916 citations

Peers

Countries citing papers authored by Matthew Hawryluk

Since Specialization

Citations

This map shows the geographic impact of Matthew Hawryluk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Hawryluk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Hawryluk more than expected).

Fields of papers citing papers by Matthew Hawryluk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Hawryluk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Hawryluk. The network helps show where Matthew Hawryluk may publish in the future.

Co-authorship network of co-authors of Matthew Hawryluk

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Hawryluk. A scholar is included among the top collaborators of Matthew Hawryluk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Hawryluk. Matthew Hawryluk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting 2017 ·Oncotarget ·Brian Dougherty, Zhongwu Lai, Darren Hodgson, Maria Orr, Matthew Hawryluk, James Sun, Roman Yelensky, Stuart Spencer, Jane Robertson, Tony W. Ho, Anitra Fielding, Jonathan A. Ledermann, J. Carl Barrett	64
2	Comprehensive genomic profiling of biliary tract cancers to reveal tumor-specific differences and genomic alterations. 2015 ·Journal of Clinical Oncology ·Jeffrey S. Ross, Kai Wang, Daniel Virgil Thomas Catenacci, Juliann Chmielecki, Siraj M. Ali, Julia A. Elvin, Roman Yelensky, Doron Lipson, Matthew Hawryluk, Vincent A. Miller, Philip J. Stephens, Milind Javle	28
3	Abstract 611: Exploratory analyses suggest ovarian tumors with somatic or germline loss of function mutations in BRCA1 or BRCA2 are biologically similar and sensitive to PARP inhibition 2015 ·Cancer Research ·Brian Dougherty, Zhongwu Lai, Jonathan A. Ledermann, Jane Robertson, Tony W. Ho, Wenting Wu, Darren Hodgson, Maria Orr, Mark J. O’Connor, Matthew Hawryluk, Timothy Brennan, Roman Yelensky, James Sun, J. Carl Barrett	3
4	Abstract 4670: A novel companion diagnostic predicts response to the PARP inhibitor rucaparib in ovarian cancer 2015 ·Cancer Research ·James Sun, Iain A. McNeish, Robert L. Coleman, Amit M. Oza, Clare L. Scott, David M. O’Malley, Kevin Lin, Christine Burns, Christine Vietz, Philip J. Stephens, (unknown), Matthew Hawryluk, Heidi Giordano, Mitch Raponi, Lindsey Rolfe, Jeff Isaacson, Vincent A. Miller, Andrew R. Allen, Elizabeth M. Swisher, Roman Yelensky	2
5	Abstract A23: Comprehensive next-generation sequencing-based genomic profiling identifies actionable genomic alterations in diverse pediatric tumor types: The Foundation Medicine (FMI) experience 2014 ·Cancer Research ·Matthew Hawryluk, Kai Wang, Juliann Chmielecki, Siraj M. Ali, Gary A. Palmer, (unknown), Emily White, Roman Yelensky, Philip J. Stephens, Jeffrey S. Ross, Vincent A. Miller	1
6	Abstract A28: Clinical next-generation sequencing (NGS) reveals genomic alterations (GAs) to guide targeted therapy in advanced neuroblastoma patients 2014 ·Cancer Research ·Siraj M. Ali, Matthew Hawryluk, Kai Wang, Juliann Chmielecki, Gary A. Palmer, (unknown), Emily White, Roman Yelensky, Philip J. Stephens, Jeffrey S. Ross, John M. Maris, V. A. Miller	1
7	New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing 2014 ·The Oncologist ·Jeffrey S. Ross, Kai Wang, Laurie M. Gay, Rami N. Al‐Rohil, Janne V. Rand, David Jones, (unknown), Christine E. Sheehan, Geoff Otto, Gary A. Palmer, Roman Yelensky, Doron Lipson, Deborah Morosini, Matthew Hawryluk, Daniel V.T. Catenacci, Vincent A. Miller, Chaitanya Churi, Siraj M. Ali, Philip J. Stephens	341
8	Clinical application of comprehensive next-generation sequencing-based genomic profiling for identification of actionable genomic alterations in pediatric solid tumors and hematolymphoid malignancies: The Foundation Medicine pediatric experience. 2014 ·Journal of Clinical Oncology ·Matthew Hawryluk, Kai Wang, Juliann Chmielecki, Siraj M. Ali, Gary A. Palmer, Sean R. Downing, John A. Curran, (unknown), Emily White, Doron Lipson, Roman Yelensky, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross	2
9	Analysis of candidate homologous repair deficiency genes in a clinical trial of olaparib in patients (pts) with platinum-sensitive, relapsed serous ovarian cancer (PSR SOC). 2014 ·Journal of Clinical Oncology ·Brian Dougherty, Jonathan A. Ledermann, (unknown), Jane Robertson, Tony W. Ho, Darren Hodgson, Mark J. O’Connor, Anitra Fielding, Matthew Hawryluk, Timothy J. Brennan, Roman Yelensky, James Sun, J. Carl Barrett	3
10	Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy 2013 ·Modern Pathology ·Jeffrey S. Ross, Kai Wang, Rami N. Al‐Rohil, Tipu Nazeer, Christine E. Sheehan, Geoff Otto, Jie He, Gary A. Palmer, Roman Yelensky, Doron Lipson, Siraj M. Ali, Sohail Balasubramanian, John A. Curran, (unknown), (unknown), Sean R. Downing, Matthew Hawryluk, Vincent A. Miller, Philip J. Stephens	119
11	Clinical next‐generation sequencing successfully applied to fine‐needle aspirations of pulmonary and pancreatic neoplasms 2013 ·Cancer Cytopathology ·Geneva Young, Kai Wang, Jie He, Geoff Otto, Matthew Hawryluk, (unknown), Tina Brennan, Michelle Nahas, Amy Donahue, Roman Yelensky, Doron Lipson, Christine E. Sheehan, Ann Boguniewicz, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross	98
12	Clinical next generation sequencing (NGS) of fine needle aspiration (FNA) biopsies in non-small cell lung (NSCLC) and pancreatic cancers. 2013 ·Journal of Clinical Oncology ·Matthew Hawryluk, Jeffrey S. Ross, Christine E. Sheehan, (unknown), Geneva Young, Geoff Otto, Roman Yelensky, Doron Lipson, Gary A. Palmer, Phil Stephens, Vincent A. Miller	1
13	Epsin 1 is a Polyubiquitin‐Selective Clathrin‐Associated Sorting Protein 2006 ·Traffic ·Matthew Hawryluk, Peter A. Keyel, Sanjay Mishra, Simon C. Watkins, John E. Heuser, Linton M. Traub	146
14	Epsin 1 is a Polyubiquitin‐Selective Clathrin‐Associated Sorting Protein 2006 ·Traffic ·Matthew Hawryluk, Peter A. Keyel, Sanjay Mishra, Simon C. Watkins, John E. Heuser, Linton M. Traub	6
15	Dual Engagement Regulation of Protein Interactions with the AP-2 Adaptor α Appendage 2004 ·Journal of Biological Chemistry ·Sanjay Mishra, Matthew Hawryluk, Tom J. Brett, Peter A. Keyel, (unknown), Anupma Jha, John E. Heuser, Daved H. Fremont, Linton M. Traub	65
16	A Novel AP-2 Adaptor Interaction Motif Initially Identified in the Long-splice Isoform of Synaptojanin 1, SJ170 2004 ·Journal of Biological Chemistry ·Anupma Jha, (unknown), Sanjay Mishra, Peter A. Keyel, Matthew Hawryluk, Linton M. Traub	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact